日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/03/26 | 1,359 | 1,385 | 1,356 | 1,365 | -8 | -0.6% | 198,000 |
| 2013/03/25 | 1,362 | 1,389 | 1,362 | 1,373 | +22 | +1.6% | 264,000 |
| 2013/03/22 | 1,355 | 1,366 | 1,351 | 1,351 | -8 | -0.6% | 282,000 |
| 2013/03/21 | 1,362 | 1,367 | 1,355 | 1,359 | +1 | +0.1% | 280,000 |
| 2013/03/19 | 1,344 | 1,366 | 1,344 | 1,358 | +16 | +1.2% | 161,000 |
| 2013/03/18 | 1,351 | 1,354 | 1,342 | 1,342 | -29 | -2.1% | 127,000 |
| 2013/03/15 | 1,320 | 1,371 | 1,320 | 1,371 | +47 | +3.5% | 217,000 |
| 2013/03/14 | 1,326 | 1,335 | 1,292 | 1,324 | +9 | +0.7% | 309,000 |
| 2013/03/13 | 1,310 | 1,321 | 1,304 | 1,315 | -13 | -1% | 173,000 |
| 2013/03/12 | 1,380 | 1,380 | 1,321 | 1,328 | -22 | -1.6% | 237,000 |
| 2013/03/11 | 1,395 | 1,395 | 1,330 | 1,350 | +61 | +4.7% | 268,000 |
| 2013/03/08 | 1,289 | 1,294 | 1,280 | 1,289 | +18 | +1.4% | 274,000 |
| 2013/03/07 | 1,269 | 1,278 | 1,262 | 1,271 | +21 | +1.7% | 82,000 |
| 2013/03/06 | 1,258 | 1,260 | 1,241 | 1,250 | -1 | -0.1% | 120,000 |
| 2013/03/05 | 1,276 | 1,280 | 1,242 | 1,251 | -7 | -0.6% | 171,000 |
| 2013/03/04 | 1,271 | 1,286 | 1,256 | 1,258 | +1 | +0.1% | 145,000 |
| 2013/03/01 | 1,235 | 1,277 | 1,230 | 1,257 | +31 | +2.5% | 249,000 |
| 2013/02/28 | 1,203 | 1,230 | 1,202 | 1,226 | +4 | +0.3% | 204,000 |
| 2013/02/27 | 1,235 | 1,242 | 1,214 | 1,222 | +7 | +0.6% | 314,000 |
| 2013/02/26 | 1,215 | 1,227 | 1,210 | 1,215 | ±0 | ±0% | 156,000 |
| 2013/02/25 | 1,197 | 1,219 | 1,197 | 1,215 | +18 | +1.5% | 86,000 |
| 2013/02/22 | 1,192 | 1,210 | 1,192 | 1,197 | -14 | -1.2% | 110,000 |
| 2013/02/21 | 1,186 | 1,224 | 1,186 | 1,211 | +19 | +1.6% | 209,000 |
| 2013/02/20 | 1,174 | 1,198 | 1,173 | 1,192 | +8 | +0.7% | 146,000 |
| 2013/02/19 | 1,185 | 1,195 | 1,180 | 1,184 | -2 | -0.2% | 119,000 |
| 2013/02/18 | 1,176 | 1,191 | 1,176 | 1,186 | +12 | +1% | 116,000 |
| 2013/02/15 | 1,171 | 1,185 | 1,171 | 1,174 | ±0 | ±0% | 185,000 |
| 2013/02/14 | 1,173 | 1,182 | 1,165 | 1,174 | -6 | -0.5% | 141,000 |
| 2013/02/13 | 1,191 | 1,193 | 1,174 | 1,180 | -14 | -1.2% | 184,000 |
| 2013/02/12 | 1,210 | 1,236 | 1,192 | 1,194 | +16 | +1.4% | 300,000 |
| 2013/02/08 | 1,169 | 1,178 | 1,134 | 1,178 | +54 | +4.8% | 315,000 |
| 2013/02/07 | 1,139 | 1,140 | 1,116 | 1,124 | -6 | -0.5% | 100,000 |
| 2013/02/06 | 1,138 | 1,140 | 1,100 | 1,130 | +23 | +2.1% | 116,000 |
| 2013/02/05 | 1,100 | 1,127 | 1,100 | 1,107 | -9 | -0.8% | 95,000 |
| 2013/02/04 | 1,130 | 1,132 | 1,103 | 1,116 | -13 | -1.2% | 186,000 |
| 2013/02/01 | 1,149 | 1,155 | 1,126 | 1,129 | -19 | -1.7% | 156,000 |
| 2013/01/31 | 1,148 | 1,153 | 1,123 | 1,148 | -15 | -1.3% | 182,000 |
| 2013/01/30 | 1,144 | 1,166 | 1,144 | 1,163 | +26 | +2.3% | 117,000 |
| 2013/01/29 | 1,140 | 1,153 | 1,137 | 1,137 | -1 | -0.1% | 70,000 |
| 2013/01/28 | 1,156 | 1,158 | 1,131 | 1,138 | -6 | -0.5% | 121,000 |
| 2013/01/25 | 1,169 | 1,169 | 1,130 | 1,144 | -17 | -1.5% | 214,000 |
| 2013/01/24 | 1,101 | 1,165 | 1,100 | 1,161 | +54 | +4.9% | 327,000 |
| 2013/01/23 | 1,088 | 1,130 | 1,083 | 1,107 | +15 | +1.4% | 186,000 |
| 2013/01/22 | 1,090 | 1,110 | 1,077 | 1,092 | -5 | -0.5% | 161,000 |
| 2013/01/21 | 1,089 | 1,104 | 1,086 | 1,097 | +3 | +0.3% | 118,000 |
| 2013/01/18 | 1,072 | 1,101 | 1,061 | 1,094 | +47 | +4.5% | 294,000 |
| 2013/01/17 | 1,096 | 1,099 | 1,036 | 1,047 | -50 | -4.6% | 330,000 |
| 2013/01/16 | 1,085 | 1,100 | 1,074 | 1,097 | +12 | +1.1% | 203,000 |
| 2013/01/15 | 1,099 | 1,111 | 1,077 | 1,085 | ±0 | ±0% | 165,000 |
| 2013/01/11 | 1,049 | 1,098 | 1,045 | 1,085 | +50 | +4.8% | 277,000 |
3051～
3100
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 374,400円 | +3.8% | -19.9% | 3.63% | 12.16倍 | 0.93倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 203,400円 | +5.9% | +684.6% | 2.70% | 13.50倍 | 1.35倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
